Obesity
Obesity
SELECT: Long-term weight loss with semaglutide versus placebo over 4 years
book_2
Source:
Obes Facts 2024;17(suppl 1):TS12.02.
calendar_today
Published on Medfyle:
May 2024
import_contacts
4
min
In this medfyle
This prespecified analysis of SELECT examined weight and anthropometric effects based on baseline demographics, weight-related, and glycaemic measures. Results suggest semaglutide is effective in people from diverse racial and geographic backgrounds, and with varied body compositions.
About this Medfyle
Read more
arrow_downward
Hide
arrow_upward
©2024 Medfyle. All rights reserved.
Source: Ryan DH, Lingvay I, Deanfield J, et al. Long-term weight loss in the SELECT trial: semaglutide 2.4 mg vs placebo over 208 weeks in a global population of 17,604 participants. Obes Facts 2024;17(suppl 1):TS12.02.
The information and data provided is for information purposes only. The author(s) of the original original presentation had no involvement in the creation of this content.
